The Community Guide

- gsearch

Search Results

Narrow Results:

2018 1
2013 2

Journal Article 3

1 - 3 of 3 Results

Refine Results

Refine Results:

Anti-respiratory syncytial virus (RSV) G monoclonal antibodies reduce lung inflammation and viral lung titers when delivered therapeutically in a BALB/c mouse model

CITE Title : Anti-respiratory syncytial virus (RSV) G monoclonal antibodies reduce lung inflammation and viral lung titers when delivered therapeutically in a BALB/c mouse model Personal Author(s) : Caidi, Hayat;Miao, Congrong;Thornburg, Natalie J.;Tripp, Ralph A.;Anderson, Larry J.;Haynes, Lia M.; Published Date : April 17 2018;6-2018; Source : Antiviral Res. 154:149-157 URL : https://stacks.cdc.gov/view/cdc/105469 Caidi, Hayat et al. (2018). Anti-respiratory syncytial virus (RSV) G monoclonal antibodies reduce lung inflammation and viral lung titers when delivered therapeutically in a BALB/c mouse model. 154 Caidi, Hayat et al. "Anti-respiratory syncytial virus (RSV) G monoclonal antibodies reduce lung inflammation and viral lung titers when delivered therapeutically in a BALB/c mouse model" 154 (2018) Caidi, Hayat et al. "Anti-respiratory syncytial virus (RSV) G monoclonal antibodies reduce lung inflammation and viral lung titers when delivered therapeutically in a BALB/c mouse model" vol. 154, 2018 Export RIS Citation Information.

:

Caidi, Hayat ;

Miao, Congrong

April 17 2018 | Antiviral Res. 154:149-157

:

RSV continues to be a high priority for vaccine and antiviral drug development. Unfortunately, no safe and effective RSV vaccine is available and trea...
Nanoparticle Vaccines Encompassing the Respiratory Syncytial Virus (RSV) G Protein CX3C Chemokine Motif Induce Robust Immunity Protecting from Challenge and Disease

CITE Title : Nanoparticle Vaccines Encompassing the Respiratory Syncytial Virus (RSV) G Protein CX3C Chemokine Motif Induce Robust Immunity Protecting from Challenge and Disease Personal Author(s) : Jorquera, Patricia A.;Choi, Youngjoo;Oakley, Katie E.;Powell, Thomas J.;Boyd, James G.;Palath, Naveen;Haynes, Lia M.;Anderson, Larry J.;Tripp, Ralph A.; Published Date : Sep 10 2013 Source : PLoS One. 2013; 8(9). URL : https://stacks.cdc.gov/view/cdc/21138 Jorquera, Patricia A. et al. (2013). Nanoparticle Vaccines Encompassing the Respiratory Syncytial Virus (RSV) G Protein CX3C Chemokine Motif Induce Robust Immunity Protecting from Challenge and Disease. 8(9). Jorquera, Patricia A. et al. "Nanoparticle Vaccines Encompassing the Respiratory Syncytial Virus (RSV) G Protein CX3C Chemokine Motif Induce Robust Immunity Protecting from Challenge and Disease" 8, no. 9 (2013) Jorquera, Patricia A. et al. "Nanoparticle Vaccines Encompassing the Respiratory Syncytial Virus (RSV) G Protein CX3C Chemokine Motif Induce Robust Immunity Protecting from Challenge and Disease" vol. 8, no. 9, 2013 Export RIS Citation Information.

:

Jorquera, Patricia A. ;

Choi, Youngjoo

Sep 10 2013 | PLoS One. 2013; 8(9).

:

Nanoparticle vaccines were produced using layer-by-layer fabrication and incorporating respiratory syncytial virus (RSV) G protein polypeptides compri...
Decrease in Formalin-Inactivated Respiratory Syncytial Virus (FI-RSV) Enhanced Disease with RSV G Glycoprotein Peptide Immunization in BALB/c Mice

CITE Title : Decrease in Formalin-Inactivated Respiratory Syncytial Virus (FI-RSV) Enhanced Disease with RSV G Glycoprotein Peptide Immunization in BALB/c Mice Personal Author(s) : Rey, Gertrud U.;Miao, Congrong;Caidi, Hayat;Trivedi, Suvang U.;Harcourt, Jennifer L.;Tripp, Ralph A.;Anderson, Larry J.;Haynes, Lia M.; Published Date : Dec 23 2013 Source : PLoS One. 2013; 8(12). URL : https://stacks.cdc.gov/view/cdc/28012 Rey, Gertrud U. et al. (2013). Decrease in Formalin-Inactivated Respiratory Syncytial Virus (FI-RSV) Enhanced Disease with RSV G Glycoprotein Peptide Immunization in BALB/c Mice. 8(12). Rey, Gertrud U. et al. "Decrease in Formalin-Inactivated Respiratory Syncytial Virus (FI-RSV) Enhanced Disease with RSV G Glycoprotein Peptide Immunization in BALB/c Mice" 8, no. 12 (2013) Rey, Gertrud U. et al. "Decrease in Formalin-Inactivated Respiratory Syncytial Virus (FI-RSV) Enhanced Disease with RSV G Glycoprotein Peptide Immunization in BALB/c Mice" vol. 8, no. 12, 2013 Export RIS Citation Information.

:

Rey, Gertrud U. ;

Miao, Congrong

Dec 23 2013 | PLoS One. 2013; 8(12).

:

Respiratory syncytial virus (RSV) is a high priority target for vaccine development. One concern in RSV vaccine development is that a non-live virus v...